Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Apr 2, 2018 at 1:20 PM EDT

Pfizer’s Late-Stage Win Not Enough to Offset Monday Market Carnage

Pfizer shares took a small step back on Monday despite announcing positive results from a late-stage trial. The pullback seems…

Chris Lange | Apr 2, 2018 at 9:40 AM EDT

FDA Gets Down on Alkermes Depression Drug

Alkermes saw its shares drop early on Monday after the company announced that it received a Refusal to File letter…

Chris Lange | Mar 31, 2018 at 8:40 AM EDT

Major Biopharma Catalysts, Conferences and Decisions to Watch For in April

Here is a 24/7 Wall St. calendar with a few of the biggest biotech and pharmaceutical companies expecting clinical trial…

Douglas A. McIntyre | Mar 31, 2018 at 8:15 AM EDT

Question for Coffee Industry: Does Beverage Cause Cancer?

A California judge ruled that one ingredient in coffee was dangerous enough to be a potential cause of cancer. The…

Chris Lange | Mar 28, 2018 at 11:25 AM EDT

What a Buyout Could Mean for Shire

Shares of Shire saw a solid gain on Wednesday after the firm announced that it received an offer to be…

Chris Lange | Mar 28, 2018 at 10:20 AM EDT

Why Edge Therapeutics Fell Off the Edge of the Earth

Edge Therapeutics saw its shares plunge massively following the results from a late-stage trial.

Chris Lange | Mar 27, 2018 at 12:10 PM EDT

Can Arrowhead Pharma Keep Up the Pace?

Arrowhead Pharmaceuticals shares made a solid gain on Tuesday after the company gave an update on its midstage study of…

Chris Lange | Mar 27, 2018 at 9:30 AM EDT

Major Biotechs See Rising Tide in Short Interest

The March 15 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Mar 27, 2018 at 8:45 AM EDT

Which Major Pharma Stocks Short Sellers Are Keen On

The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Mar 26, 2018 at 11:55 AM EDT

Why ImmunoGen Could See Another 60% of Potential Upside

ImmunoGen shares benefited after the company presented data for its latest assessment of mirvetuximab soravtansine at the Society of Gynecologic Oncology…

Lee Jackson | Mar 26, 2018 at 10:05 AM EDT

4 Jefferies Biotech Stocks to Buy That Could Be Acquired Within 18 Months

While there is no guarantee that these four biotech companies are acquired, they are outstanding stocks to own in aggressive…

Chris Lange | Mar 24, 2018 at 8:25 AM EDT

How Analysts See AbbVie After the Big Disappointment

AbbVie shares took a big step back last week after the firm reported less than favorable results for its relapsed/refractory…

Chris Lange | Mar 23, 2018 at 10:25 AM EDT

Pfizer’s Chantix Study Goes Up in Smoke

Pfizer shares slipped slightly on Friday after the pharma giant announced results from its Chantix/Champix smoking cessation study in adolescents.

Chris Lange | Mar 23, 2018 at 9:50 AM EDT

Is the FDA Expecting More Problems for Progenics?

Progenics Pharmaceuticals shares took a big step back on Friday after the firm announced that it received an update from…

Chris Lange | Mar 22, 2018 at 11:50 AM EDT

AbbVie Slides on Weak Midstage Results

AbbVie saw its shares pull back on Thursday after it reported less than favorable midstage results for its relapsed/refractory small…

1 … 138 139 140 141 142 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Pfizer’s Late-Stage Win Not Enough to Offset Monday Market Carnage

FDA Gets Down on Alkermes Depression Drug

Major Biopharma Catalysts, Conferences and Decisions to Watch For in April

Question for Coffee Industry: Does Beverage Cause Cancer?

What a Buyout Could Mean for Shire

Why Edge Therapeutics Fell Off the Edge of the Earth

Can Arrowhead Pharma Keep Up the Pace?

Major Biotechs See Rising Tide in Short Interest

Which Major Pharma Stocks Short Sellers Are Keen On

Why ImmunoGen Could See Another 60% of Potential Upside

4 Jefferies Biotech Stocks to Buy That Could Be Acquired Within 18 Months

How Analysts See AbbVie After the Big Disappointment

Pfizer’s Chantix Study Goes Up in Smoke

Is the FDA Expecting More Problems for Progenics?

AbbVie Slides on Weak Midstage Results

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Health and Healthcare Articles

All Health and Healthcare Articles

Pfizer’s Late-Stage Win Not Enough to Offset Monday Market Carnage

FDA Gets Down on Alkermes Depression Drug

Major Biopharma Catalysts, Conferences and Decisions to Watch For in April

Question for Coffee Industry: Does Beverage Cause Cancer?

What a Buyout Could Mean for Shire

Why Edge Therapeutics Fell Off the Edge of the Earth

Can Arrowhead Pharma Keep Up the Pace?

Major Biotechs See Rising Tide in Short Interest

Which Major Pharma Stocks Short Sellers Are Keen On

Why ImmunoGen Could See Another 60% of Potential Upside

4 Jefferies Biotech Stocks to Buy That Could Be Acquired Within 18 Months

How Analysts See AbbVie After the Big Disappointment

Pfizer’s Chantix Study Goes Up in Smoke

Is the FDA Expecting More Problems for Progenics?

AbbVie Slides on Weak Midstage Results

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how